Researchers Fine-Tune blood thinner doses for chinese hearts
NCT ID NCT05320627
Summary
This study aimed to understand how the blood-thinning drug edoxaban works in the bodies of Chinese patients with a common heart rhythm disorder called atrial fibrillation. Researchers followed 150 patients taking the drug for 12 weeks, collecting blood samples to measure drug levels and effects. The goal was to create a better model for predicting the right dose for Chinese patients to improve safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON VALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100037, China
Conditions
Explore the condition pages connected to this study.